The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M02 | Topical products for joint and muscular pain | |
| 3 | M02A | Topical products for joint and muscular pain | |
| 4 | M02AA | Antiinflammatory preparations, non-steroids for topical use | |
| 5 | M02AA08 | Felbinac |
| Active Ingredient | Description | |
|---|---|---|
| Felbinac |
Felbinac is an active metabolite of fenbufen, belonging to the family of medicines known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is used as a gel for local treatment of pain and inflammation associated with conditions of the musculo-skeletal system. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| TRAXAM Cutaneous foam | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
